Aimmune Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
DBV Jumps 41% To $9.96 After Update On Viaskin Peanut Filing
Article By: The Fly
Wednesday, February 13, 2019 5:49 PM EDT
Shares of DBV Technologies jumped after the company said that its planned resubmission of the Biologics License Application to the FDA for Viaskin Peanut is anticipated in the third quarter of 2019.
In this article: DBVT Also: AIMT
Read
Morning Call For Wednesday, Feb. 21
Article By: Jim Van Meerten
Wednesday, February 21, 2018 9:29 AM EDT
Mar E-mini S&Ps (ESH18 unch) this morning are down -0.05% and European stocks are down -0.57% after European manufacturing activity slowed more than expected this month.
In this article: BYD, FLR, LZB, MOS, CATM, CYBE, HALO, REGN, TXRH, VRSK, LPSN, LC, AIMT
Read
Premarket Biotech Digest – Teva, MannKind, Quidel, Applied DNA Sciences Reported Earnings
Article By: KKD Healthcare Analytics
Friday, May 12, 2017 5:40 AM EDT
Teva Pharmaceutical Industries announced its first quarter results. Applied DNA Sciences reported its second quarter loss at $3.4 million.
In this article: BSX, MNKD, QDEL, STAA, TEVA, XNCR, CRBP, AIMT, APDN, NSPR
Read

Latest Tweets for $AIMT

No tweets yet!

PARTNER HEADLINES

$AIMT

Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
Michael Levin 6/6/2022 10:03:46 PM

Remember, Grand Slams also come with strikeouts with the bases loaded. For me to list them all would be to tout that this one will be one of them. That said, for the helluvit the one I loved the most was $AIMT. They had a peanut allergy drug that the FDA approved and the stock was around $31-35 the day it happened. Nestle stepped up and bought 20% of the Co. for $31 in early 2020. Covid hit and many stocks got crushed and stayed there. Later in August the EU put out a report on how good the drug was as well as earlier in the Summer the FDA struck down a competitors drug attempt at peanut allergies. I said to myself "Here is $AIMT at $12.90 (Fri Aug 28th) and with no more potential competition as well as EU "loving" this drug, Nestle has got to step up and buy the rest of this Co." and I bought the Sep $15 calls for $.25  That Monday Nestle bought them out for $32.40 or so and I sold those calls for $19.10 roughly 71:1 payoff. I was shocked that I bought these calls on a Fri on a whim and the next trading day $AIMT was the #1 stock in the world for % gain. True story. I have MANY stories of the opposite as well, where I lost All, so these things do NOT happen often.  Best of luck.

Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
Walken Talken 6/3/2022 6:16:47 PM

Remember, Grand Slams also come with strikeouts with the bases loaded. For me to list them all would be to tout that this one will be one of them. That said, for the helluvit the one I loved the most was $AIMT. They had a peanut allergy drug that the FDA approved and the stock was around $31-35 the day it happened. Nestle stepped up and bought 20% of the Co. for $31 in early 2020. Covid hit and many stocks got crushed and stayed there. Later in August the EU put out a report on how good the drug was as well as earlier in the Summer the FDA struck down a competitors drug attempt at peanut allergies. I said to myself "Here is $AIMT at $12.90 (Fri Aug 28th) and with no more potential competition as well as EU "loving" this drug, Nestle has got to step up and buy the rest of this Co." and I bought the Sep $15 calls for $.25  That Monday Nestle bought them out for $32.40 or so and I sold those calls for $19.10 roughly 71:1 payoff  I was shocked that I bought these calls on a Fri on a whim and the next trading day $AIMT was the #1 stock in the world for % gain. True story. I have MANY stories of the opposite as well, where I lost All, so these things do NOT happen often.  Best of luck

1 to 2 of 2 comments